Medication info

Clovant Tablet (Acyclovir)

Prescription medicationTabletIntravenous injectionExpired
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
AJU Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Expired

MFDS item code 201906190 · Approved 2019.08.30

This product's status changed to Expired on 2024.08.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of herpes zoster and herpes simplex; prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, administration is preferably started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg 2 ~ 3 times daily and further reduced after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this medicine at 800 mg 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Because patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is usually no higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/minute), this medicine is preferably administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/minute, this medicine is preferably administered at a reduced dose of 800 mg twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/minute, this medicine is preferably administered at a reduced dose of 800 mg 3 times daily, at approximately 8-hour intervals.
Child administration
Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children 2 years and older: Administer this medicine at 20 mg/kg per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
AJU Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster and herpes simplex; prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • shingles virus infections
  • acute pain from shingles
  • chickenpox
View approved original text

This medication is effective in the treatment and prevention of herpes simplex virus infections, including primary and recurrent genital herpes. It is also used for the treatment of shingles virus infections, particularly in relieving acute pain. However, its effectiveness for post-herpetic neuralgia has not yet been conclusively proven. Lastly, it is used to treat chickenpox in children over 2 years old. It is widely used for the treatment of various viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, administration is preferably started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg 2 ~ 3 times daily and further reduced after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this medicine at 800 mg 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Because patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is usually no higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/minute), this medicine is preferably administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/minute, this medicine is preferably administered at a reduced dose of 800 mg twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/minute, this medicine is preferably administered at a reduced dose of 800 mg 3 times daily, at approximately 8-hour intervals.

Child administration

Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children 2 years and older: Administer this medicine at 20 mg/kg per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used by patients who are allergic to this drug or its ingredients. Caution should be exercised in patients with impaired kidney function, as neurological symptoms may be more easily manifested. Patients with impaired liver function should be administered carefully due to the risk of further deterioration of liver function. In infants and children, it should be used minimally and only when necessary, particularly in newborns and low-birth-weight infants where safety has not been established, requiring stricter precautions. Elderly patients may have decreased kidney function, which can lead to the medication remaining in the body longer, hence increasing the risk of adverse reactions; therefore, dosage and intervals should be adjusted and adequate hydration is needed. While using this medication, serious allergic reactions such as shock or anaphylaxis may occur; if symptoms such as low blood pressure, difficulty breathing, or chest tightness manifest, administration should be stopped immediately and appropriate treatment should be sought. If symptoms of phototoxicity, skin rash, fever, blisters, or urticaria appear, discontinue the medication and consult a physician. Serious skin reactions such as hair loss, severe dermatitis, Stevens-Johnson syndrome, and Lyell syndrome may occur, requiring close monitoring of skin condition. Neurological symptoms may include altered consciousness, disorientation, decreased concentration, aggression, hallucinations, convulsions, drowsiness, tremors, anxiety, and insomnia, particularly in elderly or patients with impaired kidney function. It may affect the kidneys, leading to renal failure, hematuria, proteinuria, so renal function should be regularly monitored. Hematological and lymphatic system side effects may include leukopenia, thrombocytopenia, bleeding, and anemia, hence blood tests should be conducted to check the condition. Liver dysfunction, hepatitis, or jaundiced symptoms may occur, so periodic liver function tests are recommended. Gastrointestinal symptoms may include gastritis, nausea, vomiting, diarrhea, constipation, and abdominal pain; these symptoms should be consulted with a doctor. Generally, this medication should be administered for 5 days for herpes simplex and chickenpox and for 7 days for shingles; if symptoms do not improve, alternative treatments should be considered. It is most effective to start treatment as early as possible when symptoms appear; for shingles, administration should begin within 5 days of skin symptom onset, and for chickenpox within 3 days. Patients with compromised immune function may consider intravenous administration. During administration, especially at high doses, it is important to maintain adequate hydration to prevent dehydration and reduce the risk of nephrotoxicity. In the treatment of recurrent genital herpes, the decision to continue treatment should be evaluated after one year. This medication may cause altered consciousness, requiring caution when driving or operating hazardous machinery, particularly in patients with impaired kidney function. There may be interactions with other medications, especially those affecting kidney function, such as probenecid, cimetidine, theophylline, and mycophenolate mofetil, so patients should consult with a doctor or pharmacist if taking these. Pregnant women or those who may become pregnant should carefully consider the risks and benefits of treatment before using this medication; since this medication is excreted in breast milk, nursing should be stopped during treatment. In the case of overdose, renal function deterioration, neurological symptoms may occur, so immediate consultation with medical personnel is necessary, and if needed, treatments such as dialysis should be pursued.

Side effects

Anaphylactic shock, anaphylactoid reaction, hypotension, dyspnea, chest tightness, photosensitivity reaction, fixed drug eruption, rash, fever, vesicles, urticaria-like erythema, urticaria, alopecia, polymorphous erythema, mucocutaneous syndrome, toxic epidermal necrolysis, altered consciousness, disorientation, concentration disturbance, aggressive behavior, depersonalization, anxiety, dysdiadochokinesia, coma, confusion, delirium, stuttering, encephalopathy, hallucinations, psychosis, convulsions, drowsiness, tremors, agitation, amnesia, insomnia, anxiety, talking to oneself, paresthesia, ataxia, inability to walk, involuntary movements, nystagmus, dizziness, renal failure, crystalluria, elevated BUN, elevated serum creatinine, hematuria, proteinuria, urinary red blood cell casts, purulent urine, vasculitis with leukocytoclastic features, lymphadenopathy, bleeding, purpura, anemia, leukopenia, leukocytosis, eosinophilia, lymphocytosis, thrombocytosis, granulocytopenia, thrombocytopenia, basophilia, hepatitis, liver dysfunction, jaundice, abnormal liver function tests, hepatomegaly, gastritis, thirst, constipation, acute pancreatitis, diarrhea, loose stools, upper abdominal pain, stomach pain, abdominal pain, nausea, vomiting, dyspepsia, loss of appetite, glossitis, fever, peripheral edema, syncope, pallor, muscle weakness, lack of energy, generalized fatigue, headache, arthralgia, myalgia, arrhythmia, chest pain, elevated blood pressure, decreased blood pressure, tachycardia, palpitations, urinary obstruction, dysuria, glycosuria, pneumonia, pharyngitis, pleural effusion, pain, hearing loss, conjunctivitis, visual disturbances, taste disturbances, hair loss, sweating, hyponatremia, decreased serum protein, elevated total cholesterol levels, elevated triglyceride levels, elevated serum potassium levels, decreased serum albumin levels, anxiety, coma, convulsions, drowsiness, confusion, hallucinations, agitation, seizure activity, state of coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature of between 1 degree and 30 degrees Celsius. This way, the effectiveness and safety of the medication can be well preserved.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.